Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations
Open accessThe DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index; none of the 234 sources its claims cite is checked for support yet.
Abstract
The production of neurotoxic amyloid-β peptides (Aβ) is central to the initiation and progression of Alzheimer's disease (AD) and involves sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. APP and the secretases are transmembrane proteins and their co-localisation in the same membrane-bound sub-compartment is necessary for APP cleavage. The intracellular trafficking of APP and the β-secretase, BACE1, is critical in regulating APP processing and Aβ production and has been studied in several cellular systems. Here, we summarise the intracellular distribution and transport of APP and its secretases, and the intracellular location for APP cleavage in non-polarised cells and neuronal models. In addition, we review recent advances on the potential impact of familial AD mutations on APP trafficking and processing. This is critical information in understanding the molecular mechanisms of AD progression and in supporting the development of novel strategies for clinical treatment.
Overview
CoChat Summary
TL;DR
This review summarizes the cell biology of APP trafficking and processing, emphasizing that APP and BACE1 are largely segregated and that amyloidogenic cleavage can occur in multiple compartments, especially the Golgi/TGN and endosomes. It highlights that familial AD mutations, notably APP Swedish, can shift the major processing site to the secretory pathway/Golgi and are linked to organelle abnormalities.
Key findings
- APP and BACE1 follow distinct post-Golgi itineraries in non-polarised cells: APP is transported from the TGN to early endosomes via AP4/Arl5b with low plasma membrane levels, while BACE1 goes directly to the plasma membrane and recycles; the TGN/Golgi and early endosomes are prime convergence sites.
- In primary neurons, APP and BACE1 show only low co-localisation under physiological conditions; synaptic activity can increase their convergence and β-cleavage products (C99) and Aβ secretion.
- The familial APP Swedish mutation (K595/M596→N595/L596 in APP695) is adjacent to the β-cleavage site; purified BACE1 cleaves APPswe faster than APPwt, with synthetic peptide cleavage 10-fold higher and kcat/Km 60-fold higher; APPswe is predominantly cleaved in the secretory pathway/Golgi, whereas APPwt is preferentially cleaved in the endocytic pathway.
- Familial AD mutations are numerous (114 APP mutations; >360 PSEN1 and >90 PSEN2 pathogenic mutations), many near the transmembrane domain/cleavage sites; PSEN mutations can alter APP trafficking and cause organelle abnormalities, including Golgi fragmentation and enlarged endosomes in iPSC-derived neurons.
Methods
- Narrative review synthesizing published literature on intracellular distribution/trafficking of APP and secretases, sites of APP processing in non-polarised cells and neuronal models, and effects of familial AD mutations.
- Evidence base includes immortalised cell lines, primary rodent neurons, rodent brain sections, human iPSC-derived neurons, and patient/post-mortem tissues; Tables 1–3 summarize localisation, cleavage products, and unanswered questions.
- Main analysis is qualitative synthesis with figures/tables; no new experimental data, systematic search, or meta-analysis.
Limitations
- Stated in paper: challenges include comparing different cell lines, overexpression effects, sorting motif/adaptor pleiotropy, antibody specificity, older microscopy resolution limits, steady-state Aβ localisation, multiple mutants in the same line, and multiple processing compartments.
- Stated in paper: many unanswered questions remain (Table 3), including when/where APP and BACE1 converge in neurons, whether disease mutations alter processing location in primary neurons, and the role of cholesterol-rich microdomains.
- Evident from text: as a narrative review, it does not systematically appraise study quality or quantify effects; conclusions rely on cited studies, many from non-neuronal or overexpression systems, with limited human neuronal data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. Trafficking itineraries of APP and the β-secretase BACE1 in non-polarised cells. Intracellular trafficking itineraries of APP and the β-secretase BACE1 in non-polarised cells are illustrated in blue and red, respectively. Both APP and BACE1 are synthesised in the endoplasmic reticulum (ER) and transported to the Golgi apparatus. APP and BACE1 segregate within the Golgi stack and are sorted into different transport carriers at the trans-Golgi network (TGN). The bulk of APP is transported to the early endosomes and then transported along the late endosome-lysosome pathway in cultured cells using protocols to synchronise trafficking of APP from the ER [47,48]. Low levels of APP are transported to the cell surface as quantified by TIRF [48] and are present at steady state as assessed by subcellular fractionation [49]. In contrast, BACE1 is sorted directly to the plasma membrane [50]. BACE1 can be actively internalised and recycled through the recycling endosomes, while APP showed minimal localisation to the recycling endosomes. Hence, the TGN and the early endosomes serve as potential sites for the β-cleavage of APP.](https://figures.cochat.ai/paper-figures/6f375d5ded924c009e2c7aa5a54b48a8/advances-in-the-cell-biology-of-the-trafficking-and-processing-of-amyloid-figure-2.jpg)



Verification
Claims the paper makes
0 Valid · 1 Not valid · 158 Not checked · 55 Own results and interpretations
A statement the paper makes itself — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As APP and the secretases are all membrane-bound proteins, the co-localisation of APP and its secretases is required for cleavage events to occur”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Trafficking and sorting of APP in non-neuronal cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The specificity of the antibodies used to detect intracellular APP needs to be rigorously defined as they often have the potential to recognise several APP fragments.”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > AD and the amyloid cascade model > Main challenges to define the intracellular locations of APP processing
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
In the paper
“somatic APP resides predominantly in the Golgi and early or late endosomes in neurons”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Intracellular distribution of APP in the polarised domains of rodent neurons
What the sources say
- Not checked yetcites [71] 2012, Amyloid precursor protein revisited neuron-specific expression and highly stable nature of soluble derivatives, J. Biol. Chem. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“APP cargo has been observed to traffic back to the TGN from the early endosomes through the retromer-mediated retrograde transport”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Trafficking and sorting of APP in non-neuronal cells
What the sources say
- Not checked yetcites [59] 2012, Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network, Proc. Natl Acad. Sci. U.S.A. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the tyrosine-based YTSI motif in the cytoplasmic tail can interact with the adaptor protein AP-3, to mediate APP traffic to the lysosomes for degradation”
§ Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations > Intracellular distribution of APP > Trafficking and sorting of APP in non-neuronal cells
What the sources say
- Not checked yetcites [67] 2016, Tyrosine binding protein sites regulate the intracellular trafficking and processing of amyloid precursor protein through a novel lysosome-directed pathway, PLoS One source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
160 more claims
Create a free account to see all 214 claims and to verify the 233 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 10
Citations
Cites
Items 201–273 of 273
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Lichtenthaler, S. F., Tschirner, S. K., & Steiner, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.003 · Cited by 60
Employing a superior BACE1 cleavage sequence to probe cellular APP processing
Tomasselli, A. G., Qahwash, I. M., Emmons, T. L., Lu, Y., Leone, J. W., Lull, J. M., Fok, K. F., Bannow, C. A., Smith, C. W., Bienkowski, M. J., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01597.x · Cited by 60
Palacios, G., Palacios, J. M., Mengod, G., & Frey, P. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90109-o · Cited by 60
Endosomal recycling reconciles the Alzheimer's disease paradox
Small, S. A., & Petsko, G. A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb1717 · Cited by 60
Muresan, V., Varvel, N. H., Lamb, B. T., & Muresan, Z. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2558-08.2009 · Cited by 59
AP‐2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons
Bera, S., Camblor‐Perujo, S., Barca, E. C., Negrete‐Hurtado, A., Racho, J., Bruyckere, E. D., Wittich, C., Ellrich, N., Martins, S., Adjaye, J., et al. (2020) · EMBO Reports · doi:10.15252/embr.201947954 · Cited by 59
Tan, J. Z. A., & Gleeson, P. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005222 · Cited by 56
Self-citationTang, T.-C., Hu, Y., Kienlen‐Campard, P., Haylani, L. E., Decock, M., Hees, J. V., Fu, Z., Octave, J., Constantinescu, S. N., & Smith, S. O. (2014) · Structure · doi:10.1016/j.str.2013.12.012 · Cited by 54
Enhanced -secretase processing alters APP axonal transport and leads to axonal defects
Rodrigues, E. M., Weissmiller, A. M., & Goldstein, L. S. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds297 · Cited by 54
Park, H., Hundley, F. V., Yu, Q., Overmyer, K. A., Brademan, D. R., Serrano, L. R., Paulo, J. A., Paoli, J. C., Swarup, S., Coon, J. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33881-x · Cited by 54
Rudajev, V., & Novotný, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01127-y · Cited by 54
Stenovec, M., Trkov, S., Lasič, E., Terzieva, S., Kreft, M., Rodriguez, J. J., Parpura, V., Verkhratsky, A., & Zorec, R. (2015) · Glia · doi:10.1002/glia.22931 · Cited by 53
Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP
DeBoer, S. R., Dolios, G., Wang, R., & Sisodia, S. S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2255-14.2014 · Cited by 51
Ludewig, S., & Korte, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00161 · Cited by 51
Bretou, M., Sannerud, R., Escamilla-Ayala, A., Leroy, T., Vrancx, C., Van Acker, Z. P., Perdok, A., Vermeire, W., Vorsters, I., Van Keymolen, S., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.030 · Cited by 51
Påhlsson, P., & Spitalnik, S. L. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0296 · Cited by 50
Localization of presenilin–nicastrin complexes and γ‐secretase activity to the trans‐Golgi network
Siman, R., & Velji, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01616.x · Cited by 49
Presenilin 1 is involved in maturation and trafficking of N‐cadherin to the plasma membrane
Uemura, K., Kitagawa, N., Kohno, R., Kuzuya, A., Kageyama, T., Chonabayashi, K., Shibasaki, H., & Shimohama, S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10753 · Cited by 49
Hasebe, N., Fujita, Y., Ueno, M., Yoshimura, K., Fujino, Y., & Yamashita, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082321 · Cited by 46
Subcellular localization of presenilins: association with a unique membrane pool in cultured cells
Kim, S.-H., Lah, J. J., Thinakaran, G., Levey, A., & Sisodia, S. S. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0280 · Cited by 45
Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease
Pantelopulos, G. A., Abraham, C. B., & Straub, J. E. (2024) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062823-023436 · Cited by 43
Chaufty, J., Sullivan, S. E., & Ho, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0602-12.2012 · Cited by 40
Tan, J. Z. A., Fourriere, L., Wang, J., Perez, F., Boncompain, G., & Gleeson, P. A. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-09-0487 · Cited by 37
Self-citationKhvotchev, M., & Südhof, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408474200 · Cited by 37
Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons
Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1120086 · Cited by 37
Wang, J., Fourrière, L., & Gleeson, P. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.597391 · Cited by 36
Self-citationNovel APP mutation V715A associated with presenile Alzheimer?s disease in a German family
Cruts, M., Dermaut, B., Rademakers, R., den Broeck, M. V., St�gbauer, F., & Broeckhoven, C. V. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0182-5 · Cited by 35
Golgi complex dynamics and its implication in prevalent neurological disorders
Caracci, M. O., Fuentealba, L. M., & Marzolo, M.-P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00075 · Cited by 35
Mórotz, G. M., Glennon, E. B. C., Greig, J., Lau, D. H. W., Bhembre, N., Mattedi, F., Muschalik, N., Noble, W. J., Vagnoni, A., & Miller, C. C. J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0857-5 · Cited by 35
Dunning, C. J. R., Black, H. L., Andrews, K. L., Davenport, E. C., Conboy, M., Chawla, S., Dowle, A. A., Ashford, D., Thomas, J. R., & Evans, G. J. O. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13571 · Cited by 34
Petanceska, S. S., Seeger, M., Checler, F., & Gandy, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741878.x · Cited by 32
The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease
Qureshi, Y. H., Berman, D. E., Marsh, S. E., Klein, R. L., Patel, V. M., Simoes, S., Kannan, S., Petsko, G. A., Stevens, B., & Small, S. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110262 · Cited by 31
Back, S., Haas, P., Tschäpe, J., Gruebl, T., Kirsch, J., Müller, U., Beyreuther, K., & Kins, S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21239 · Cited by 31
Novel T719P AβPP Mutation Unbalances the Relative Proportion of Amyloid-β Peptides
Ghidoni, R., Albertini, V., Squitti, R., Paterlini, A., Bruno, A., Bernardini, S., Cassetta, E., Rossini, P. M., Squitieri, F., Benussi, L., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1142 · Cited by 30
Steinhilb, M. L., Turner, R. S., & Gaut, J. R. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00764.x · Cited by 30
Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1
Sun, M., & Zhang, H. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.024 · Cited by 29
The C99 domain of the amyloid precursor protein resides in the disordered membrane phase
Capone, R. F., Tiwari, A., Hadziselimovic, A., Peskova, Y. B., Hutchison, J. M., Sanders, C. R., & Kenworthy, A. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100652 · Cited by 29
Roselli, S., Şatır, T. M., Camacho, R., Fruhwürth, S., Bergström, P., Zetterberg, H., & Agholme, L. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01374-0 · Cited by 29
Martínez-Mármol, R., Mohannak, N., Qian, L., Wang, T., Gormal, R. S., Ruitenberg, M. J., Vanhaesebroeck, B., Coulson, E. J., & Meunier, F. A. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0674-19.2019 · Cited by 28
Mini-review: amyloid degradation toxicity hypothesis of Alzheimer's disease
Zaretsky, D. V., & Zaretskaia, M. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135959 · Cited by 28
Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer’s Disease
Deaton, C. A., & Johnson, G. V. W. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200598 · Cited by 27
Intracellular trafficking of TREM2 is regulated by presenilin 1
Zhao, Y., Li, X., Huang, T. Y., Jiang, L.-L., Tan, Z., Zhang, M., Cheng, I. H.-J., Wang, X., Bu, G., Zhang, Y., et al. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.200 · Cited by 26
Antonino, M., Marmo, P., Freites, C. L., Quassollo, G., Sánchez, M. F., Lorenzo, A., & Bignante, E. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.852738 · Cited by 26
Gandy, S., Zhang, Y., Ikin, A., Schmidt, S. D., Levy, E., Sheffield, R., Nixon, R. A., Liao, F., Mathews, P. M., Xu, H., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04587.x · Cited by 25
X11/Mint Genes Control Polarized Localization of Axonal Membrane Proteins in Vivo
Gross, G. G., Lone, G. M., Leung, L. K., Hartenstein, V., & Guo, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5749-12.2013 · Cited by 25
Wang, J., Daniszewski, M., Hao, M. M., Hernández, D., Pébay, A., Gleeson, P. A., & Fourriere, L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112709 · Cited by 25
Self-citationPresenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2
Wang, W., Moerman, A., Slaton, A., & Barger, S. W. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.005 · Cited by 24
Tam, J. H. K., Cobb, M. R., Seah, C., & Pasternak, S. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161445 · Cited by 24
Schilling, S., Pradhan, A., Heesch, A., Helbig, A., Blennow, K., Koch, C., Bertgen, L., Koo, E. H., Brinkmalm, G., Zetterberg, H., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01577-y · Cited by 24
Shin, R., Saido, T. C., Maeda, M., & Kitamoto, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.032 · Cited by 22
Importance of the subcellular location of protein deposits in neurodegenerative diseases
Bertolotti, A. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.03.004 · Cited by 22
Dehury, B., Somavarapu, A. K., & Kepp, K. P. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107648 · Cited by 22
Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane
Wang, M., Jing, T., Wang, X., & Yao, D. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.016 · Cited by 20
Pan, J., Sun, D., Lee, D., Xiong, L., Ren, X., Guo, H.-H., Yao, L., Lu, Y., Jung, C., & Xiong, W. (2021) · Communications Biology · doi:10.1038/s42003-021-02843-2 · Cited by 20
Wang, Q., Jia, J., Qin, W., Wu, L., Li, D., Wang, Q., & Li, H. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143231 · Cited by 18
Wang, J., Gleeson, P. A., & Fourriere, L. (2024) · Traffic · doi:10.1111/tra.12932 · Cited by 18
Self-citationLin, S., Leitão, A. D. G., Fang, S., Gu, Y., Barber, S., Gilliard-Telefoni, R., Castro, A., Sung, K., Shen, R., Florio, J. B., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106010 · Cited by 17
Aow, J., Huang, T.-R., Goh, Y. T., Sun, A. X., Thinakaran, G., & Koo, E. H. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112774 · Cited by 16
Presenilins: how much more than γ-secretase?!
Coen, K., & Annaert, W. G. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381474 · Cited by 16
Conformational Effects of the A21G Flemish Mutation on the Aggregation of Amyloid β Peptide
Yagi‐Utsumi, M., & Dobson, C. M. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00466 · Cited by 16
Fourriere, L., Cho, E. H., & Gleeson, P. A. (2022) · Traffic · doi:10.1111/tra.12831 · Cited by 16
Self-citationVillegas, C., Muresan, V., & Ladescu Muresan, Z. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt555 · Cited by 15
Assembly of γ-secretase occurs through stable dimers after exit from the endoplasmic reticulum
Wouters, R., Michiels, C., Sannerud, R., Kleizen, B., Dillen, K., Vermeire, W., Escamilla‐Ayala, A., Demedts, D., Schekman, R. W., & Annaert, W. G. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.201911104 · Cited by 14
Yu, Y., Gao, Y., Winblad, B., Tjernberg, L. O., & Schedin-Weiss, S. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-215008 · Cited by 12
Shah, S. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.4 · Cited by 10
Lipid transfer proteins and the tuning of compartmental identity in the Golgi apparatus
McDermott, M. I., & Mousley, C. J. (2016) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2016.06.005 · Cited by 10
Par3 regulates polarized convergence between APP and BACE1 in hippocampal neurons
Sun, M., Huang, C., Wang, H., & Zhang, H. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.01.023 · Cited by 10
Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease
Gouras, G. K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00185 · Cited by 10
Li, N., Qiu, Y., Wang, H., Zhao, J., & Qing, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416151 · Cited by 9
Neuronal apoptosis is accompanied by amyloid β-protein accumulation in the endoplasmic reticulum
Borghi, R., Pellegrini, L., Lacaná, E., Diaspro, A., Pronzato, M. A., Vitali, A., Roncarati, R., Strocchi, P., Zaccheo, D., D'adamio, L., et al. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4104 · Cited by 8
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
The US9-derived protein gPTB9TM modulates APP processing without targeting secretase activities
Brandimarti, R., Irollo, E., & Meucci, O. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03153-2 · Cited by 3
Immunobiology of Proteins and Peptides IV: T-Cell Recognition and Antigen Presentation
(1987) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-5442-0 · Cited by 2
Research works printed but not linked: 1
- 2000, Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis, Ann. Neurol., 47, 249, 10.1002/1531-8249(200002)47:2<249::aid-ana18>3.0.co;2-8 · doi:10.1002/1531-8249(200002)47:2<249::aid-ana18>3.0.co;2-8
Cited by
Revisiting the role of Annexins in membrane trafficking
Grewal, T., Gerke, V., Nylandsted, J., Rentero, C., & Enrich, C. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05780-z · Cited by 20
Gioé-Gallo, C., Ortigueira, S., Prieto‐Díaz, R., Contino, M., Azuaje, J., Perrone, M. G., Riganti, C., Alberga, D., Mangiatordi, G. F., Andújar-Arias, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00604 · Cited by 8
Alameen, A. A. M., Al‐kuraishy, H. M., Al-Gareeb, A. I., Shokr, M. M., & Batiha, G. E. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104947 · Cited by 7
Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6
Self-citationImpact of Golgi dynamics and Golgi morphology on the regulation of glycosylation
Gleeson, P. A. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130919 · Cited by 3
Self-citation
Metadata
- Authors
- Wang, J., Fourriere, L., & Gleeson, P. A.
- Affiliations
- The University of Melbourne (AU)
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
- Corresponding author
- Gleeson, Paul A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2024-09-20
- Volume
- 481
- Issue
- 19
- Pages
- 1297-1325
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC11555708
- OpenAlex
- W4402681980
- Cited by
- 27
- References
- 273
- Citations by year
- 2026: 19 · 2025: 8
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochemical Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Medical Research Council
- National Health and Medical Research Council (2013384)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid precursor protein, amyloid-beta, Alzheimer's disease, familial Alzheimer's disease mutations, BACE1, beta-secretase, gamma-secretase, APP processing, intracellular trafficking, APP cleavage, neuron models
- MeSH terms
- Alzheimer Disease, Animals, Humans, Mutation, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Protein Transport, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.